Along with distress that comes with cancer diagnosis and the discomfort of treatment, more patients now have to deal with “financial toxicity”, the expense, anxiety and loss of confidence confronting those who face large, unpredictable costs.
Researchers have now developed a tool to measure a patient’s risk for, and ability to tolerate, financial stress that comes with cancer.
Named COST (Comprehensive Score for financial Toxicity), the tool comprises 11 questions, assembled and refined from conversations with more than 150 patients with advanced cancer.
“A few physicians discuss this increasingly significant side effect with their patients,” said Jonas de Souza, head-and-neck cancer specialist at University of Chicago Department of Medicine in the US.
“We believe that a thoughtful, concise tool that could help predict a patient’s risk for financial toxicity might open the lines of communication. This gives us a way to launch that discussion,” de Souza added.
- Shah Rukh Khan On Raees Clash With Kaabil: It’s Impossible To Have A Solo Release In India
- US-President Elect Donald Trump Named TIME’s Person Of The Year 2016
- O. Panneerselvam: 10 Things You Need To Know
- PM Narendra Modi Slams Opposition For Not Letting Parliament Function
- Nawazuddin Siddiqui On Working In Raees: Was Nervous To Shoot With Shah Rukh Khan
- Bathinda Dancer Murder: Video Showing Accused Opening Fire At Marriage
- 5 Lesser Known Facts About Sasikala Natarajan
- Congress Leader Shashi Tharoor’s Delhi Home Burgled: Here’s What Happened
- Reserve Bank Of India Keeps Repo Rate Unchanged Post Demonetisation
- Bigg Boss 10 Dec 06 Review: Swami Om Pees In Kitchen
- Lenovo k6 Power Video Review
- Bigg Boss 10 December 5 Review: Manveer Calls Swami Om ‘kachdaa’
- PM Narendra Modi Declared Winner Of TIME Magazine’s Person Of The Year – Reader’s Poll
- Paneerselvam sworn in as new Chief Minister of Tamil Nadu
- Tamil Nadu CM J Jayalalithaa Passes Away After Suffering Cardiac Arrest
Explaining the utility of the tool, he noted, “If patients know what to expect, they may want their physicians to consider less costly medications.”
The findings appeared in the journal Cancer.